Sartorius Stedim Biotech Stock
Stocks
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Real-time
Euronext Paris
04:30:20 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 181.40 EUR | +0.61% |
|
+4.07% | -13.62% |
| 08-12 | Sartorius Stedim Biotech : RBC remains its Buy rating | ZD |
| 07-28 | SARTORIUS STEDIM BIOTECH : Buy rating from Bernstein | ZD |
| Market Cap | 17.54B 20.25B 16.44B 14.99B 28.18B 1,931B 28.62B 193B 75.57B 967B 76.02B 74.37B 3,224B | P/E 2026 * |
46.2x | P/E 2027 * | 35.8x |
|---|---|---|---|---|---|
| Enterprise Value | 19.55B 22.57B 18.32B 16.71B 31.41B 2,152B 31.9B 215B 84.22B 1,078B 84.73B 82.89B 3,594B | EV / Sales 2026 * |
6.25x | EV / Sales 2027 * | 5.57x |
| Free-Float |
28.47% | Yield 2026 * |
0.47% | Yield 2027 * | 0.57% |
Last Transcript: Sartorius Stedim Biotech
| 1 day | +1.05% | ||
| 1 week | +4.53% | ||
| Current month | +9.30% | ||
| 1 month | -3.75% | ||
| 3 months | +13.31% | ||
| 6 months | +4.14% | ||
| Current year | -13.24% |
| 1 week | 173.8 |  | 183 |
| 1 month | 158.9 | | 190.8 |
| Current year | 150 | | 224 |
| 1 year | 150 | | 224 |
| 3 years | 139.1 | | 281 |
| 5 years | 139.1 | | 551 |
| 10 years | 50.13 | | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/17/25 | Sell | Company | 750,000 | 0.7706% | ||
| 2/16/24 | Buy | Chief Executive Officer | 1,716,739 | 1.8624% | ||
| 3/2/22 | Sell | Company | 200,442 | 0.2174% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.05% | +4.53% | +3.52% | -31.56% | 20.25B | |
| +1.08% | +4.92% | -15.35% | +5.32% | 192B | |
| +0.09% | +5.55% | -1.43% | +8.76% | 116B | |
| -5.90% | -0.96% | +8.65% | +67.67% | 59.95B | |
| +2.11% | +4.26% | +33.94% | +64.61% | 54.64B | |
| +1.20% | +7.57% | -5.84% | -34.97% | 50B | |
| +1.42% | +9.85% | +13.26% | -18.70% | 34.26B | |
| +1.31% | -3.18% | - | - | 31.15B | |
| +0.26% | +0.36% | +46.85% | -10.75% | 24.79B | |
| +0.85% | +13.34% | -6.26% | +23.46% | 24.07B | |
| Average | +0.35% | +4.18% | +8.59% | +8.20% | 60.72B | |
| Weighted average by Cap. | +0.29% | +4.25% | +0.88% | +11.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13B 3.61B 2.93B 2.67B 5.02B 344B 5.1B 34.45B 13.47B 172B 13.55B 13.25B 575B | 3.47B 4B 3.25B 2.96B 5.57B 382B 5.65B 38.2B 14.93B 191B 15.02B 14.69B 637B |
| Net income | 379M 437M 355M 324M 609M 41.73B 618M 4.18B 1.63B 20.89B 1.64B 1.61B 69.67B | 481M 555M 451M 411M 773M 52.95B 785M 5.3B 2.07B 26.51B 2.08B 2.04B 88.4B |
| Net Debt | 2.01B 2.32B 1.88B 1.72B 3.23B 221B 3.28B 22.15B 8.66B 111B 8.71B 8.52B 369B | 1.76B 2.04B 1.65B 1.51B 2.83B 194B 2.88B 19.43B 7.6B 97.19B 7.64B 7.47B 324B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-13 | €181.40 | +0.61% | 2,714 |
| 26-08-12 | €180.30 | -0.06% | 60,904 |
| 26-08-11 | €180.40 | -0.55% | 81,644 |
| 26-08-10 | €181.40 | +1.97% | 57,783 |
| 26-08-07 | €177.90 | +2.07% | 63,610 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions
